Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-048483

Options or other derivatives

  • President acquired 545,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ryan Charles S. President 2023-09-01 Grant or award · Employee Stock Option (right to buy) +545,000 545,000 D: show line 1 in the form
Loading xslF345X05/doc4.xml…